Oncovista Innovative Therapies Stock Probability of Future Pink Sheet Price Finishing Over 8.4E-5
| OVIT Stock | USD 0.0002 0.0001 100.00% |
OncoVista |
OncoVista Innovative Target Price Odds to finish over 8.4E-5
The tendency of OncoVista Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.000084 in 90 days |
| 0.0002 | 90 days | 0.000084 | more than 93.0 |
Based on a normal probability distribution, the odds of OncoVista Innovative to stay above $ 0.000084 in 90 days from now is more than 93.0 (This OncoVista Innovative Therapies probability density function shows the probability of OncoVista Pink Sheet to fall within a particular range of prices over 90 days) . Probability of OncoVista Innovative price to stay between $ 0.000084 and its current price of $2.0E-4 at the end of the 90-day period is more than 93.0 .
Given the investment horizon of 90 days OncoVista Innovative Therapies has a beta of -1.39. This indicates as returns on its benchmark rise, returns on holding OncoVista Innovative Therapies are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, OncoVista Innovative is expected to outperform its benchmark. Moreover OncoVista Innovative Therapies has an alpha of 1.6642, implying that it can generate a 1.66 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). OncoVista Innovative Price Density |
| Price |
Predictive Modules for OncoVista Innovative
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OncoVista Innovative. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.OncoVista Innovative Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. OncoVista Innovative is not an exception. The market had few large corrections towards the OncoVista Innovative's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold OncoVista Innovative Therapies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of OncoVista Innovative within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.66 | |
β | Beta against Dow Jones | -1.39 | |
σ | Overall volatility | 0.000012 | |
Ir | Information ratio | 0.11 |
OncoVista Innovative Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OncoVista Innovative for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OncoVista Innovative can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OncoVista Innovative is way too risky over 90 days horizon | |
| OncoVista Innovative has some characteristics of a very speculative penny stock | |
| OncoVista Innovative appears to be risky and price may revert if volatility continues | |
| OncoVista Innovative Therapies currently holds 479.3 K in liabilities. OncoVista Innovative has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist OncoVista Innovative until it has trouble settling it off, either with new capital or with free cash flow. So, OncoVista Innovative's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OncoVista Innovative sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OncoVista to invest in growth at high rates of return. When we think about OncoVista Innovative's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OncoVista Innovative Therapies currently holds about 61.27 K in cash with (232.38 K) of positive cash flow from operations. |
OncoVista Innovative Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OncoVista Pink Sheet often depends not only on the future outlook of the current and potential OncoVista Innovative's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OncoVista Innovative's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Long Term Debt | 208.3 K |
OncoVista Innovative Technical Analysis
OncoVista Innovative's future price can be derived by breaking down and analyzing its technical indicators over time. OncoVista Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of OncoVista Innovative Therapies. In general, you should focus on analyzing OncoVista Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
OncoVista Innovative Predictive Forecast Models
OncoVista Innovative's time-series forecasting models is one of many OncoVista Innovative's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary OncoVista Innovative's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about OncoVista Innovative
Checking the ongoing alerts about OncoVista Innovative for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for OncoVista Innovative help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| OncoVista Innovative is way too risky over 90 days horizon | |
| OncoVista Innovative has some characteristics of a very speculative penny stock | |
| OncoVista Innovative appears to be risky and price may revert if volatility continues | |
| OncoVista Innovative Therapies currently holds 479.3 K in liabilities. OncoVista Innovative has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist OncoVista Innovative until it has trouble settling it off, either with new capital or with free cash flow. So, OncoVista Innovative's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OncoVista Innovative sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OncoVista to invest in growth at high rates of return. When we think about OncoVista Innovative's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OncoVista Innovative Therapies currently holds about 61.27 K in cash with (232.38 K) of positive cash flow from operations. |
Additional Tools for OncoVista Pink Sheet Analysis
When running OncoVista Innovative's price analysis, check to measure OncoVista Innovative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoVista Innovative is operating at the current time. Most of OncoVista Innovative's value examination focuses on studying past and present price action to predict the probability of OncoVista Innovative's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoVista Innovative's price. Additionally, you may evaluate how the addition of OncoVista Innovative to your portfolios can decrease your overall portfolio volatility.